TY - JOUR
T1 - ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer
T2 - 2022 Update
AU - Expert Panel on Urologic Imaging:
AU - Turkbey, Baris
AU - Oto, Aytekin
AU - Allen, Brian C.
AU - Akin, Oguz
AU - Alexander, Lauren F.
AU - Ari, Mim
AU - Froemming, Adam T.
AU - Fulgham, Pat F.
AU - Gettle, Lori Mankowski
AU - Maranchie, Jodi K.
AU - Rosenthal, Seth A.
AU - Schieda, Nicola
AU - Schuster, David M.
AU - Venkatesan, Aradhana M.
AU - Lockhart, Mark E.
N1 - Publisher Copyright:
© 2023 American College of Radiology
PY - 2023/5
Y1 - 2023/5
N2 - Prostate cancer has a wide spectrum ranging between low-grade localized disease and castrate-resistant metastatic disease. Although whole gland and systematic therapies result in cure in the majority of patients, recurrent and metastatic prostate cancer can still occur. Imaging approaches including anatomic, functional, and molecular modalities are continuously expanding. Currently, recurrent and metastatic prostate cancer is grouped in three major categories: 1) Clinical concern for residual or recurrent disease after radical prostatectomy, 2) Clinical concern for residual or recurrent disease after nonsurgical local and pelvic treatments, and 3) Metastatic prostate cancer treated by systemic therapy (androgen deprivation therapy, chemotherapy, immunotherapy). This document is a review of the current literature regarding imaging in these settings and the resulting recommendations for imaging. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
AB - Prostate cancer has a wide spectrum ranging between low-grade localized disease and castrate-resistant metastatic disease. Although whole gland and systematic therapies result in cure in the majority of patients, recurrent and metastatic prostate cancer can still occur. Imaging approaches including anatomic, functional, and molecular modalities are continuously expanding. Currently, recurrent and metastatic prostate cancer is grouped in three major categories: 1) Clinical concern for residual or recurrent disease after radical prostatectomy, 2) Clinical concern for residual or recurrent disease after nonsurgical local and pelvic treatments, and 3) Metastatic prostate cancer treated by systemic therapy (androgen deprivation therapy, chemotherapy, immunotherapy). This document is a review of the current literature regarding imaging in these settings and the resulting recommendations for imaging. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
KW - Appropriate Use Criteria
KW - Appropriateness Criteria
KW - AUC
KW - Biochemical recurrence
KW - Fluciclovine PET
KW - Metastatic prostate cancer
KW - MRI
KW - Prostate cancer
KW - PSMA PET
UR - http://www.scopus.com/inward/record.url?scp=85160092065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85160092065&partnerID=8YFLogxK
U2 - 10.1016/j.jacr.2023.02.012
DO - 10.1016/j.jacr.2023.02.012
M3 - Article
C2 - 37236741
AN - SCOPUS:85160092065
SN - 1546-1440
VL - 20
SP - S164-S186
JO - Journal of the American College of Radiology
JF - Journal of the American College of Radiology
IS - 5
ER -